26th BioPharma Drug Discovery Nexus 2026

May 7th & 8th 2026

Philadelphia Airport Marriott, PA, USA

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

Driving Progress Across the Drug Discovery Landscape



The BioPharma Drug Discovery Nexus is an exclusive conference that brings together leading drug discovery scientists, R&D executives, and biotech & innovative technology partners from across the biopharmaceutical industry.

The conference agenda is meticulously curated to address critical challenges across the drug discovery continuum from target identification and validation to lead optimization and translational science. It highlights emerging scientific breakthroughs, evolving discovery platforms, and real-world strategies adopted by pioneering organizations that are shaping the future of therapeutic innovation.

A Premium, All-Inclusive Experience

Every delegate is treated as a VIP. From curated networking sessions to carefully designed experiences, the Nexus fosters both professional engagement and personal comfort, creating the ideal environment for productive dialogue and long-lasting connections.

Driving Conversations in Drug Discovery

This is not a conventional tradeshow. The Nexus is purposefully structured to bring together senior leaders in a focused setting that supports strategic discussions, peer learning, and professional exchange.

Curated One-to-One Engagements

Engage with fellow delegates through dedicated one-to-one meetings throughout the event. This flexible format allows you to explore strategic collaborations, exchange insights, and maximize every interaction.

Who Should Attend?

By Seniority Level

Top Management
(C-Suite, Presidents)
Senior Management
(VPs, Heads)
Middle Management
(Directors, Managers)
Others
30%
43%
22%
5%
  • Neuroscience and Preclinical Research
  • Research & Product Development
  • Precision Medicine
  • Pharmacology and Pharmacokinetics
  • Drug Discovery Innovation
  • Biomarker Research
  • Stem Cell Genomics
  • Molecular Design
  • Translational Program
  • Nonclinical Development
  • Oligonucleotide Chemistry Research
  • Oncology Cell Therapy Innovation
  • Cell & Gene Therapy
  • Toxicology
  • Modeling & Simulation
  • Computational Designing
  • Target Biochemistry
  • Protein Engineering
  • Hit Discovery
  • Medicinal Chemistry
  • High-Throughput Protein Expression
  • Assay Development
  • Bioinformatics and AI/ML
  • Therapeutic Antibodies
  • Structural Chemistry
  • Neuroscience Research
  • DMPK
  • Process Analytical Development
  • mRNA Protein Therapeutics
  • Peptide Chemistry
  • Computational Biology & Data Science
  • Computer Aided Drug Design
  • Synthetic Biology
  • Vaccine Immunology
  • Small Molecule Research
  • Machine Learning
  • Protein Biochemistry

Our Industry Leaders

Meet the Innovators Driving the Next Era of Drug Discovery

Eric B. Kmiec
Eric B. Kmiec

Chief Executive Officer

CorriXR Therapeutics

LinkedIn
Manjunatha Shivaraju
Manjunatha Shivaraju

Principal Scientist/Lab Head

Boehringer Ingelheim

LinkedIn
Nikolaos Tezapsidis
Nikolaos Tezapsidis

President & CEO

Neurotez

LinkedIn
Xiaofeng Li
Xiaofeng Li

Principal Scientist (Analytical Development)

Aurion Biotech

LinkedIn
Rakesh Dixit, Ph.D., DABT
Rakesh Dixit, Ph.D., DABT

Co-founder, President and CSO

Regio Biosciences

LinkedIn
KENNEDY OKECHUKWU
KENNEDY OKECHUKWU

Senior Scientist

Iovance Biotherapeutics, Inc.

LinkedIn
Olivier Bezy
Olivier Bezy

Senior Director - Head of Exploratory

Cellarity

LinkedIn
Tian Zhao
Tian Zhao

Vice President, R&D

OncoNano Medicine, Inc.

LinkedIn
Lital Magid
Lital Magid

Director, DMPK Team and Project Leader

Teva Pharmaceuticals

LinkedIn
Ernane Souza
Ernane Souza

Associate Director, Translational Medicine PKPD & DMPK

Supernus Pharmaceuticals, Inc.

LinkedIn
Satarupa Mukherjee
Satarupa Mukherjee

R&D Leader, AI/ML

Roche

LinkedIn
Kambiz Shekdar
Kambiz Shekdar

Founder & CEO

Secondcell Bio

LinkedIn
Dr. Fengbo Ren
Dr. Fengbo Ren

Founder and CEO

Fovus

LinkedIn
Petrina Kamya, Ph.D.
Petrina Kamya, Ph.D.

Global Head of AI Platforms, VP Insilico Medicine

Insilico Medicine

LinkedIn
Tarek Al-Aydi
Tarek Al-Aydi

Technical Sales Specialist (NY/NJ)

NanoTemper Technologies Co.

LinkedIn
Ilayaraja Muthuramu
Ilayaraja Muthuramu

Principal Scientist

Johnson & Johnson Innovative Medicine

LinkedIn
Raluca Budiu-Predoiu
Raluca Budiu-Predoiu

Director of Precision Medicine

AbbVie

LinkedIn
Roshanak Tolouei Semnani
Roshanak Tolouei Semnani

Executive Director Translational Research

Precigen

LinkedIn
Perceval Sondag
Perceval Sondag

Head of Nonclinical Biostatistic

Sanofi

LinkedIn
Raphael G. Ognar, MSc MBA
Raphael G. Ognar, MSc MBA

President & CEO, Co Founder - Chairman of the Board

NKILT Therapeutics

LinkedIn
Laura Hong
Laura Hong

Co-Founder & CEO

Ala R7

LinkedIn
Nikhil Jain, Ph. D.
Nikhil Jain, Ph. D.

Senior Scientist

Insitro

LinkedIn
Matthew Clark
Matthew Clark

Vice President of Data Science

Ability Biotherapeutics

LinkedIn
Amita Goel
Amita Goel

CEO, Founder

Celltheon Corporation

LinkedIn
Marci Newnham
Marci Newnham

East Coast and Canada Biopharma Business Development Manager

Hologic Diagenode

LinkedIn
Siobhan Gartland, PhD
Siobhan Gartland, PhD

Epigenomics Application Specialist

Hologic Diagenode

LinkedIn
Mark Budde
Mark Budde

Co-founder and CEO

Plasmidsaurus

LinkedIn
Justin Blethrow
Justin Blethrow

Product Manager

Plasmidsaurus

LinkedIn
LiMing Shen
LiMing Shen

Head of R&D Data Governance and Strategy, R&D Data Office

Sanofi

LinkedIn
Artem Evdokimov
Artem Evdokimov

VP - Head of Research

Orogen Therapeutics

LinkedIn
Abhijat Vatsyayan
Abhijat Vatsyayan

Head of Artificial Intelligence and Innovation

Taiho Oncology

LinkedIn
Ziv Kirshner
Ziv Kirshner

Senior Director, Head of Mass Spectrometry & Multiomics Innovation

Noveome Biotherapeutics, Inc.

LinkedIn
Pablo Lapuerta
Pablo Lapuerta

Chief Executive Officer

4M Therapeutics

LinkedIn
Alison Heick Varghese
Alison Heick Varghese

Principal Scientist

Pfizer

LinkedIn

6 Reasons to Attend

Gain Insight into Cutting-Edge Science & Technologies

Discover the latest innovations in target discovery, novel modalities, and AI-enabled drug design.

Learn from Industry Trailblazers

Hear proven strategies and real-world insights from leading drug discovery and R&D experts.

Address Real Drug Discovery Challenges

Explore solutions to key challenges across target validation, optimization, and early development.

High-Value, Curated Networking

Connect with senior discovery leaders and solution providers in an exclusive, invitation-only setting.

Practical, Actionable Takeaways

Take home applicable frameworks and case studies to strengthen discovery productivity.

Stay Ahead of Market & Research Trends

Keep pace with emerging scientific, technological, and strategic trends shaping drug discovery.

What to expect at
the 2026 Edition

Our 2026 agenda is built around five core themes, each designed to address the most pressing challenges and opportunities in modern drug discovery and translational research. These themes guide scientific discussions, spark innovation, foster collaboration, and provide actionable strategies to accelerate R&D, enhance candidate development, and drive meaningful impact across the industry.

  • Novel Targets & Modalities
  • Antibody & Protein Therapeutics
  • Data, AI & Computational Discovery
  • Translational Biology, Biomarkers & DMPK
  • Enabling Platforms & Tools

Industry Leaders and Innovators Who Make Things Happen

  • Drive Innovation: Senior executives and innovators actively implementing new technologies, strategies, and operational solutions in supply chain and logistics.
  • Stay Ahead: Professionals seeking the latest insights on market trends, regulatory developments, and emerging best practices.
  • Collaborate Strategically: Leaders looking to form partnerships that solve complex supply chain and operational challenges.
  • Accelerate Performance: Experts focused on enhancing efficiency, optimizing processes, and driving measurable results across the supply chain.

Your opportunity to gain insights, practical strategies, and valuable industry connections.

  • Engage with Industry Leaders
  • Hands-On Learning
  • Shape the Conversation
  • Build Strategic Connections
  • High-level plenaries with leading drug discovery experts
  • Hands-on sessions exploring emerging technologies and innovative approaches
  • Targeted networking designed to foster collaborations and scientific partnerships

Our Partners

Our Previous Partners

Our Media Partners

Showcase Your Solutions at the 26th Drug Discovery Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative drug discovery solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of drug discovery and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real operational impact.

BFSI 2026

Schedule At a Glance

8:00 am - 8:15 am
Registration
8:15 am - 8:20 am
Welcome & Chairperson Address
8:25 am - 8:45 am
Presentation 1
8:50 am - 9:10 am
Presentation 2
9:15 am - 10:10 am
Panel Discussion 1
10:15 am - 11:45 am
Networking Break
11:45 am - 12:05 pm
Presentation 3
12:10 pm - 12:30 pm
Presentation 4
12:35 pm - 12:55 pm
Presentation 5
1:00 pm - 1:40 pm
Lunch Break
Hot Buffet Lunch will be Served.
1:40 pm - 2:00 pm
Presentation 6
2:05 pm - 3:00 pm
Panel Discussion 2
3:05 pm - 3:25 pm
Presentation 7
3:30 pm - 3:55 pm
Presentation 8
4:00 pm - 5:30 pm
Networking Break
5:35 pm - 5:40 pm
Closing Remarks
8:00 am - 8:15 am
Registration
8:15 am - 8:20 am
Welcome & Chairperson Address
8:25 am - 8:45 am
Presentation 1
8:50 am - 9:10 am
Presentation 2
9:15 am - 10:10 am
Panel Discussion 1
10:15 am - 11:45 am
Networking Break
11:45 am - 12:05 pm
Presentation 3
12:10 pm - 12:30 pm
Presentation 4
12:35 pm - 12:55 pm
Presentation 5
1:00 pm - 1:40 pm
Lunch Break
Hot Buffet Lunch will be Served.
1:40 pm - 2:00 pm
Presentation 6
2:05 pm - 3:00 pm
Panel Discussion 2
3:05 pm - 3:25 pm
Presentation 7
3:30 pm - 3:55 pm
Presentation 8
4:00 pm - 5:30 pm
Networking Break
5:35 pm - 5:40 pm
Closing Remarks

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Venue

Philadelphia Airport Marriott

Name: Philadelphia Airport Marriott

Address: Philadelphia Airport Marriott, 1 Arrivals Road, Philadelphia, PA, United States

Wi-Fi: Complimentary basic Wi-Fi will be provided for all attendees.

Parking: Discounted parking will be available for conference participants throughout the event days (Discounted Parking Rate will be $15 per day).

Hotel Reservation Link: A dedicated reservation link will be shared to help you secure your accommodation at a special discounted rate. The discounted room rate is $269 per night + tax, available on a first-come, first-served basis until the cut-off date of May 9, 2026. After this date, standard hotel rates may apply based on availability.

CONFERENCE REGISTRATION

Secure your spot today.